AzTrials
AzTrials

Pain, AcuteNCT04280796

Changes in Affective Pain Processing in Human Volunteers

A study testing psychophysical tasks and cognitive task in people with Pain, Acute and Pain, Chronic, run by susanne becker at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The experience of pain is more than the conscious perception of nociceptive signals. Emotional and motivational aspects accompany pain, leading to its aversiveness and motivation for avoidance. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Pain, Acute, Pain, Chronic, Low Back Pain
What is being tested?
psychophysical tasks and cognitive task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
183 participants
Where
1 siteSwitzerland
Study dates
21 Sep 2020to 1 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • good overall health status
  • sufficient knowledge of German or English to follow instructions
  • ability to give written informed consent
  • unspecific musculoskeletal chronic pain
  • sufficient knowledge of German or English to follow instructions
  • ability to give written informed consent

Who cannot join

  • pain longer than >3 consecutive days and on more than 30 days within the last 12 months
  • major psychiatric or neurological disorders, and substance abuse
  • consumption of alcohol, illegal drugs, and analgesic drug within 24 hours before testing
  • For chronic pain patients
  • major psychiatric or neurological disorders, excluding depression and anxiety, and substance abuse
  • consumption of alcohol, illegal drugs, and analgesic drugs within 24 hours before testing

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Balgrist Campus

    Zurich, 8008

Other trials in Switzerland

About this study

Official title: Mechanisms of Emotional-motivational Pain Processing in Health and Disease

The experience of pain is more than the conscious perception of nociceptive signals. Emotional and motivational aspects accompany pain, leading to its aversiveness and motivation for avoidance. In chronic pain, a negative hedonic shift has been proposed that is characterized by disproportionally increased emotional-motivational compared to sensory-discriminative pain responses. Such a negative hedonic shift is, for example, mirrored in very high comorbidity rates of chronic pain and affective disorders such as depression and anxiety. The aim of this study is to develop methods that allow the differentiation of sensory-discriminative and emotional-motivational pain response and to characterize mechanisms of the negative hedonic shift.

Read the detailed description

The experience of pain is more than the conscious perception of nociceptive signals. Emotional and motivational aspects accompany pain, leading to its aversiveness and motivation for avoidance. In chronic pain, a negative hedonic shift has been proposed that is characterized by disproportionally increased emotional-motivational compared to sensory-discriminative pain responses. Such a negative hedonic shift is, for example, mirrored in very high comorbidity rates of chronic pain and affective disorders such as depression and anxiety. However, appropriate psychophysical methods to differentiate sensory-discriminative and emotional-motivational pain processing in humans are lacking. Therefore, only indirect evidence on the assumed negative hedonic shift in chronic pain is available, albeit understanding the mechanisms of such a shift would increase our knowledge on the development and maintenance of chronic pain in important ways with impact beyond pain research. The aim of this study is to develop methods that allow the differentiation of sensory-discriminative and emotional-motivational pain response and to characterize mechanisms of the negative hedonic shift.

A potential benefit of the study will be an increase in the knowledge on mechanisms of the development and maintenance of chronic pain with a focus on emotional-motivational processes likely also relevant in other diseases such as affective disorders.

This study involves only minimal risks for participants. The methods that will be used in the experimental investigations are within the range of standard procedures in pain research and experimental psychology and are frequently used in healthy participants and patients. Experimental pain stimulation will be adjusted to individual pain sensitivity, rendering the applied stimulation tolerable.

Substudy 1 Each participant will perform one testing session of approximately 1.5h duration at the Balgrist Campus, Balgrist University Hospital, Zurich. Healthy volunteers (N=31) will be recruited. The testing session will comprise a discrimination task and an avoidance task to assess sensory-discriminative and emotional-motivational pain components independently of each other. The tasks will be performed in counterbalanced order. After obtaining written informed consent, participants' individual heat pain threshold and tolerance will be determined, based on which the stimulation intensity to be used in the discrimination and the avoidance task will be calculated. After this assessment, participants either perform the discrimination or the avoidance task. Within the discrimination task, participants have to indicate whether they perceived a small increase in temperature or not. In the avoidance task, participants can avoid a painful stimulation by reacting fast enough to a visual cue. Participants will be randomly (balanced randomization) assigned to one of two learning conditions, either reinforcing successful discrimination or avoidance, to increase sensory-discriminative or emotional-motivational pain responses. Reinforcement, implemented by small monetary wins, will start depending on the condition after half the trials of the discrimination or the avoidance task. Subjective ratings of perceived pain intensity and unpleasantness will be assessed within both tasks as control variables to test whether increases in sensory-discriminative or emotional-motivational pain processing generalize to the subjective response channel. At the end of the testing session, participants will complete several questionnaires to investigate whether certain personality traits are related to learning capacity as tested in these tasks.

Substudy 2 Each participant will perform one testing session of approximately 1.5h duration at the Balgrist Campus, Balgrist University Hospital, Zurich. The sample will consist of patients with unspecific musculoskeletal chronic pain (N=31) and age- and sex-matched healthy controls (N=31). As in Substudy 1, the testing session will comprise the discrimination task and the avoidance task to assess sensory-discriminative and emotional-motivational pain components independently of each other. The tasks will be performed in counterbalanced order. After obtaining written informed consent, participants' individual heat pain threshold and tolerance will be determined, based on which the stimulation intensity to be used in the discrimination and the avoidance task will be calculated. After this assessment, participants either perform the discrimination or the avoidance task as in Substudy 1. In contrast to Substudy 1, reinforcement in the avoidance task will be implemented to decrease emotional-motivational pain responses because it is assumed that patients show already increased emotional-motivational compared to sensory-discriminative pain processing. Subjective ratings of perceived pain intensity and unpleasantness will be assessed within both tasks as control variables to test whether increases in sensory-discriminative or emotional-motivational pain processing generalize to the subjective response channel. At the end of the testing session, participants will complete several questionnaires, to investigate whether certain personality traits are related to heightened emotional-motivational pain processing.

Sample sizes for Substudy 1 and 2 are based on a priori sample size calculations using G*Power 3.1 with a desired medium effect size f=0.25, alpha=0.05, beta=0.80, repeated measures ANOVA between-within-subject designs, and an attrition rate of 10%. Outcome variables () will be analyzed in separate mixed model analyses for ANOVA designs with appropriate within- and between-subject factors. Associations of primary endpoints () with personality traits (secondary outcomes) will be analyzed using Person- or Spearman correlation coeffients, where appropriate. Significance levels will be set to 5%, adjusted with false discovery rate for multiple testing. Effect sizes will be calculated in terms of generalized η2 and Cohen's d.

Substudy 3 Each participant will perform one testing session of approximately 1.25h duration at the Balgrist Campus, Balgrist University Hospital, Zurich. Healthy volunteers (N=30) will be recruited. During testing session participants will perform a psychophysical task to assess metacognition in pain perception as an indicator of the cognitive-evaluative pain component. The objective is to assess whether metacognition on pain perception are involved and subjective ratings of perceived pain and how metacognition relates to pain intensity. After obtaining written informed consent, participants' individual heat pain threshold and tolerance will be determined, based on which the stimulation intensity to be used in the experiment will be calculated. After this assessment, participants perform the cognitive pain task. Within this task, participants have to indicate whether they perceived a first or second heat pain stimulus as higher in intensity, whether the higher one was perceived as painful or not, and their confidence in both these answers. In addition, participants will complete several questionnaires to investigate whether certain personality traits and personal states are related to metacognition in pain.

The sample size of Substudy 3 is determined according to Kreft and Leeuw (2007) after which a great enough power will be reached with a sample size of 30 participants and 30 observations to identify cross-level interactions. Substudy 3 follows a within subject design with repeated measures. The tasks that will be performed by each participant include the within-subject factor 'temperature difference' (differences in temperature between first and second stimulus) and the within-subject factor 'temperature level' (temperature relative to individual pain threshold of each stimulus). The order of the different conditions in each task will be applied using a balanced pseudo-randomized order. For testing hypothesis 1ai, 1bi and 1c t-test will be conducted. For Hypothesis 1aii and 1bii chi square tests are planned. To test hypothesis 2a, 2c and 3 logistic hierarchic liner models and for hypothesis 2b and 2d hierarchic linear models will be performed.

Within this study methods that allow the separation of different components of the perception of pain will be developed and validated and which are currently not available. In addition, based on theses methods, a human model on how such components of pain can dissociate will be developed, thereby allowing investigating a prominent assumption on factors that crucially contribute to the development and maintenance of chronic pain. The expected results will form the basis for the development of novel mechanism-based pain therapies.

Psychophysical methods based on experimental psychology and pain research will be used, which have been shown before to be successful in investigating different aspects of pain perception and the modulation of pain perception. The methods used are in the standard range of methods from human pain research and experimental psychology and hold only minimal risk for participants (see above "Risk / Benefit Assessment").

Being tested
psychophysical tasks, cognitive task
Keywords
acute pain, chronic pain, low back pain, hedonic shift, emotional-motivation components of pain, sensory-discriminative components of pain, operant conditioning, metacognition
Medical subject headings
Acute Pain, Chronic Pain, Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • psychophysical tasksBehavioural

    All participants perform two psychophysical tasks to assess sensory-discriminative and emotional-motivational pain responses independently from each other.

    In addition, in Substudy 1 an operant learning paradigm will be implement to dissociate these responses, increasing the sensory-discriminative pain responses compared to emotional-motivational pain responses by contingent monetary reinforcement or vice versa.

    In Substudy 2, responses of chronic pain patients will be compared to those of healthy participants to characterize possible alterations and operant learning will be operationalized to decrease emotional-motivational pain responses, which are assumed to be already increased in the patients.

  • cognitive taskBehavioural

    In Substudy 3 participants will perform a psychophysical task to assess metacognition in pain perception as an indicator of the cognitive-evaluative pain component.

Study groups in NCT04280796
Study groupRoleWhat they receive
Substudy 1ExperimentalAll participants will perform two psychophysical tasks to assess sensory-discriminative and emotional-motivational pain responses independently from each other. No arms will perform. In addition, in Substudy 1 an operant learning paradigm will be implemented to dissociate these responses, increasing the sensory-discriminative pain responses compared to emotional-motivational pain responses by contingent monetary reinforcement and vice versa. Primary objectives: 1. To develop psychophysical methods that allow the independent assessment of sensory-discriminative and emotional-motivational pain responses and 2. to show that emotional-motivational and sensory-discriminative pain components can be dissociated Secondary objective: To assess whether fear of pain, fear-avoidance beliefs, pain catastrophizing, and sensation seeking as personality traits can explain variations in how strongly sensory-discriminative and emotional-motivational pain responses can be dissociated
Receives: Behavioral: psychophysical tasks
Substudy 2ExperimentalAll participants will perform two psychophysical tasks to assess sensory-discriminative and emotional-motivational pain responses independently from each other. No arms will perform. In addition, in Substudy 2, responses of chronic pain patients will be compared to those of healthy participants to characterize possible alterations in the patients and operant learning will be operationalized to decrease emotional-motivational pain responses, which are assumed to be already increased in the patients. Primary objective: To demonstrate that in chronic pain patients, emotional-motivational pain responses are increased relative to sensory-discriminative pain responses Secondary objective: To assess whether fear of pain, fear-avoidance beliefs, pain catastrophizing, and sensation seeking as personality traits can explain variations in the present dissociation of sensory-discriminative and emotional-motivational pain responses in chronic pain patients
Receives: Behavioral: psychophysical tasks
Substudy 3ExperimentalAll participants will perform a psychophysical task to assess metacognition in pain perception as an indicator of the cognitive-evaluative pain component. No arms will perform. Primary objective: To assess whether metacognition on pain perception are involved and subjective ratings of perceived pain and how metacognition relates to pain intensity. Secondary objective: To assess whether confidentiality as a personality trait , pain catastrophizing, and skin conductance responses are related to metacognition in pain.
Receives: Behavioral: cognitive task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ratio of sensory to emotional pain responses

    Ratio of the number of correct responses (%) in a task assessing sensory-discriminative pain responses to number of correct responses (%) in a task assessing emotional-motivational pain responses.

    Measured: during the procedure

Secondary outcomes (11)
  1. reaction time (RT)

    reaction times

    Measured: during the procedure

  2. pain threshold

    Individual pain threshold assessed with experimental heat pain

    Measured: baseline

  3. pain tolerance

    Individual pain tolerance assessed with experimental heat pain

    Measured: baseline

  4. perceived pain intensity

    Individual perceived pain intensity assessed with experimental heat pain

    Measured: during the procedure

  5. perceived pain unpleasantness

    Individual perceived pain unpleasantness assessed with experimental heat pain

    Measured: during the procedure

  6. Fear of Pain Questionnaire (FPQ-III)

    FPQ-III is one questionnaire which is a widely used to assess the fear of pain (FOP) in clinical and non clinical samples. It is one self-report instrument that was developed specifically to assess fear of different stimuli usually causing pain.

    Time duration <5minutes Five point Likert scale Score range (30-150) A higher score indicates higher fear of pain, no cut-off values

    Measured: during the procedure at day one

  7. Pain Catastrophizing Scale (PCS)

    The PCS was developed in 1995 at the University Centre for Research on Pain and Disability in order to facilitate research on the mechanisms by which catastrophizing impacts on pain experience. Catastrophizing is currently defined as: an exaggerated negative mental set brought to bear during actual or anticipated painful experience.

    Time duration less than 5minutes Five point Likert scale Score range (0-52) <20 low risk for development of chronicity 20-30 moderate risk for development of chronicity >30 high risk for development of chronicity

    Measured: during the procedure at day one

  8. Fear of Avoidance Beliefs FABQ

    FABQ focuses on how a patient's fear avoidance beliefs about physical activity and work may affect and contribute to their low back pain and resulting disability

    Time duration 5-10minutes Seven point Likert scale Score range (0-96) Higher score indicates fear avoidance behaviors

    Measured: during the procedure at day one

  9. Personal Evaluation Inventory (PEI)

    PEI asses among other things ones trait confidence which might be related to metacognition in pain.

    Measured: during procedure

  10. skin conductance responses

    individual skin conductance reaction on heat stimuli during the behavioural task

    Measured: during procedure

  11. confidence ratings on forced choice questions

    Answers on forced-choice questions on which one of two heat stimuli was more intense and whether this one was perceived as painful, ratings of confidence. The answers on the forces-choice questions together with their ratings of confindence in these answers provide a measurement of metacognition.

    Measured: during procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2020
  2. Study start21 Sep 2020
  3. Primary completion1 Nov 2023
  4. Study completion1 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Study comprises an intervention that is neither a therapeutic or transplant product nor a transplant. Study involves minimal risks for participants. Used methods are within the range of standard methods frequently used in pain research. All participants will perform 2 psychophysical tasks to assess sensory-discriminative \& emotional-motivational pain responses independently from each other. Substudy1: An operant learning paradigm will be implemented to dissociate these responses, increasing the sensory-discriminative compared to emotional-motivational pain responses by contingent monetary reinforcement \& vice versa. Substudy2: Responses of chronic pain patients will be compared to those of healthy participants to characterize possible alterations. Operant learning will be operationalized to decrease emotional-motivational pain responses, which are assumed to be increased in patients. Substudy3: Participants will perform a psychophysical task to assess metacognition in pain perception.
Masking
Single blind
Who is masked
Participant
Enrolment
183 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04280796
Sponsor's protocol ID
PR00P1_179697/1
Status last verified
Nov 2023
First submitted
15 Jan 2020
Last updated
21 Nov 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing psychophysical tasks and cognitive task in people with Pain, Acute and Pain, Chronic, run by susanne becker at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ratio of sensory to emotional pain responses (time frame: during the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in